{"id":1221,"date":"2002-08-01T12:05:00","date_gmt":"2002-08-01T10:05:00","guid":{"rendered":"https:\/\/der-arzneimittelbrief.com\/artikel\/2002\/das-bfarm-gibt-bekannt-aenderungen-des-zulassungsstatus-auf-der-basis-von-einzelnen-spontanberichten-januar-bis-dezember-2001"},"modified":"2022-03-17T14:10:08","modified_gmt":"2022-03-17T13:10:08","slug":"das-bfarm-gibt-bekannt-aenderungen-des-zulassungsstatus-auf-der-basis-von-einzelnen-spontanberichten-januar-bis-dezember-2001","status":"publish","type":"post","link":"https:\/\/der-arzneimittelbrief.com\/artikel\/2002\/das-bfarm-gibt-bekannt-aenderungen-des-zulassungsstatus-auf-der-basis-von-einzelnen-spontanberichten-januar-bis-dezember-2001","title":{"rendered":"Das BfArM gibt bekannt: \u00c4nderungen des Zulassungsstatus auf der Basis von einzelnen Spontanberichten (Januar bis Dezember 2001)"},"content":{"rendered":"<p>Aus dieser Tabelle ist ersichtlich, welche neuen unerw\u00fcnschten Arzneimittelwirkungen und Wechselwirkungen bereits eingef\u00fchrter Arzneimittel dem BfArM bekannt geworden sind und zu Konsequenzen gef\u00fchrt haben.<\/p>\n","protected":false},"excerpt":{"rendered":"<p>Aus dieser Tabelle ist ersichtlich, welche neuen unerw\u00fcnschten Arzneimittelwirkungen und Wechselwirkungen bereits eingef\u00fchrter Arzneimittel dem BfArM bekannt geworden sind und zu Konsequenzen gef\u00fchrt haben.<\/p>\n","protected":false},"author":1,"featured_media":0,"comment_status":"closed","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[1],"tags":[127,126,137,255,302,3025,594,3024,730,729,257,303,3023,727,72,725,2766,3022,136,298,297],"class_list":["post-1221","post","type-post","status-publish","format-standard","hentry","category-allgemein","tag-amiodaron","tag-antiarrhythmika","tag-antikoagulanzien","tag-arzneimittel","tag-beipackzettel","tag-buflomedil","tag-ciclosporin","tag-gadopentetsaeure-dimegluminsalz","tag-gp-iib-iiia-rezeptor-antagonisten","tag-gp-iib-iiia-rezeptor-blocker","tag-medikamente","tag-packungsbeilage","tag-teufelskrallenwurzel-extrakt","tag-thrombozytenaggregationshemmer","tag-ticlopidin","tag-tirofiban","tag-tranexamsaeure","tag-vitamin-komplex","tag-warfarin","tag-waschzettel","tag-zulassungsstatus-von-arzneimitteln"],"_links":{"self":[{"href":"https:\/\/der-arzneimittelbrief.com\/api\/wp\/v2\/posts\/1221","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/der-arzneimittelbrief.com\/api\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/der-arzneimittelbrief.com\/api\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/der-arzneimittelbrief.com\/api\/wp\/v2\/users\/1"}],"replies":[{"embeddable":true,"href":"https:\/\/der-arzneimittelbrief.com\/api\/wp\/v2\/comments?post=1221"}],"version-history":[{"count":0,"href":"https:\/\/der-arzneimittelbrief.com\/api\/wp\/v2\/posts\/1221\/revisions"}],"wp:attachment":[{"href":"https:\/\/der-arzneimittelbrief.com\/api\/wp\/v2\/media?parent=1221"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/der-arzneimittelbrief.com\/api\/wp\/v2\/categories?post=1221"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/der-arzneimittelbrief.com\/api\/wp\/v2\/tags?post=1221"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}